Aandelen in “Computer Peripherals”

Aandeel Datum Koers Evolutie
vlag Quantum Corp. 30/04 10,800 USD
-3,66% 		-3,66%

Nieuws over “Computer Peripherals”

30/04 · Ease2pay NV realiseert positieve EBITDA · Persbericht

30/04 · Ease2pay NV realiseert positieve EBITDA · Persbericht

30/04 · Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th · Persbericht

29/04 · Clinical AI Platforms Expand Globally Amid Regulatory and Market Tailwinds · Persbericht

29/04 · Socket Mobile Introduces World's Smallest, Most Affordable Direct Part Mark (DPM) Barcode Scanner · Persbericht

29/04 · BrainStorm's NurOwn® Data Selected as Breakthrough Science for Presentation at ISCT 2025 Meeting · Persbericht

24/04 · Socket Mobile Reports First Quarter 2025 Results · Persbericht

17/04 · Socket Mobile Announces First Quarter 2025 Results Release Date and Conference Call · Persbericht

14/04 · Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio · Persbericht

12/04 · EXTREME NETWORKS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Extreme Networks, Inc. - EXTR · Persbericht

10/04 · BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn® in ALS · Persbericht

9/04 · Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology · Persbericht

8/04 · Socket Mobile Enters $27B Handheld Computing Market with iOS-Powered Ruggedized Devices · Persbericht

7/04 · Interlink Electronics to Participate at the Planet MicroCap Showcase April 23-24, 2025 · Persbericht

1/04 · Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th · Persbericht

31/03 · BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update · Persbericht

27/03 · Interlink Electronics Reports Fourth Quarter and Full Year 2024 Results · Persbericht

26/03 · BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq · Persbericht

25/03 · Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines · Persbericht

24/03 · Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine · Persbericht

24/03 · BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update · Persbericht

Mijn selecties